Lepu Medical sviluppa reagenti quantitativi fluorometrici per rilevare il virus del vaiolo delle scimmie
-
2022-08-11
-
LEPU
According to the WHO news announcement, the monkeypox epidemic has found about 26,000 confirmed cases of monkeypox in more than 88 countries and regions, constituting the highest level of alert of "public health event of international concern (PHEIC)"! This has raised concerns about the spread of the virus. According to the WHO, Europe is currently a high-risk area for monkeypox, and the rest of the world is at a medium-risk level.
In risposta allo scoppio globale del vaiolo delle scimmie, Lepu Medical ha sviluppato un kit per il test dell'acido nucleico (metodo PCR-Fluorescence Probe) per il virus del vaiolo delle scimmie e ha ottenuto la certificazione CE dell'UE. Questo reagente fornisce una soluzione per aiutare i laboratori di vari paesi a eseguire in modo efficiente i test dell'acido nucleico del vaiolo delle scimmie e la diagnosi rapida.
Lepu Medical's monkeypox virus detection kit has the characteristics of high detection sensitivity, easy operability and strong stability. The kit can be quickly applied on multiple platforms such as Lepgen-96, Roche LightCycler 480 series, Bio-Rad CFX96, Shanghai Hongshi SLAN, and ABI 7500. At present, Lepu Medical has received orders and inquiries from many overseas countries and, at the same time, actively promotes the registration of this product in other overseas countries.

